Lifetime risk of symptomatic knee osteoarthritis by Murphy, Louise et al.
Lifetime Risk of Symptomatic Knee Osteoarthritis
LOUISE MURPHY, PhD1, TODD A. SCHWARTZ, DrPH2, CHARLES G. HELMICK, MD3, 
JORDAN B. RENNER, MD2, GAIL TUDOR, PhD4, GARY KOCH, PhD2, ANCA DRAGOMIR, 
PhD5, WILLIAM D. KALSBEEK, PhD2, GHEORGHE LUTA, PhD6, and JOANNE M. JORDAN, 
MD, MPH2
1Business Computer Applications, Atlanta, Georgia 2University of North Carolina, Chapel Hill 
3CDC, Atlanta, Georgia 4Huston College, Bangor, Maine 5National Institute of Child Health and 
Human Development, NIH, Bethesda, Maryland 6Georgetown University Medical Center, 
Washington, DC.
Abstract
Objective—To estimate the lifetime risk of symptomatic knee osteoarthritis (OA), overall and 
stratified by sex, race, education, history of knee injury, and body mass index (BMI).
Methods—The lifetime risk of symptomatic OA in at least 1 knee was estimated from logistic 
regression models with generalized estimating equations among 3,068 participants of the Johnston 
County Osteoarthritis Project, a longitudinal study of black and white women and men age ≥45 
years living in rural North Carolina. Radiographic, sociodemographic, and symptomatic knee data 
measured at baseline (1990–1997) and first followup (1999–2003) were analyzed.
Results—The lifetime risk of symptomatic knee OA was 44.7% (95% confidence interval [95% 
CI] 40.0–49.3%). Cohort members with history of a knee injury had a lifetime risk of 56.8% (95% 
CI 48.4–65.2%). Lifetime risk rose with increasing BMI, with a risk of 2 in 3 among those who 
were obese.
Conclusion—Nearly half of the adults in Johnston County will develop symptomatic knee OA 
by age 85 years, with lifetime risk highest among obese persons. These current high risks in 
Johnston County may suggest similar risks in the general US population, especially given the 
increase in 2 major risk factors for knee OA, aging, and obesity. This underscores the immediate 
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need for greater use of clinical and public health interventions, especially those that address 
weight loss and self-management, to reduce the impact of having knee OA.
INTRODUCTION
Arthritis is among the leading causes of disability in the US (1), and osteoarthritis (OA) is 
the most common type of arthritis (2). Knee OA, the most frequent form of lower extremity 
OA (3), was the primary diagnosis for 430,000 hospital discharges and $14 billion of 
hospital charges in the 2004 US National Inpatient Sample (4), and 12.1% (annualized 
prevalence) of Americans age ≥60 years had symptomatic radiographic knee OA in the 
1991–1994 National Health and Nutrition Examination Survey (5). Although these 
population-based measures demonstrate the profound clinical and public health burden of 
knee OA, they are poor at conveying the person-level risk to the general public.
One statistic that has been used extensively to describe person-level risk is lifetime risk, 
which is the probability of developing a condition over the course of a lifetime. Lifetime risk 
has been reported for various chronic conditions and risk factors, including coronary heart 
disease (6), hypertension (7), diabetes (8), and breast cancer (9). This measure conveys the 
risk of these conditions in terms that are understandable to both clinical and lay audiences.
The purpose of this study was to estimate the lifetime risk of developing a disabling and 
relatively common type of arthritis, symptomatic knee OA, therefore increasing the general 
public’s understanding of the risk of arthritis.
PARTICIPANTS AND METHODS
Study population
We analyzed data from the Johnston County Osteoarthritis (OA) Project, a population-
based, longitudinal, prospective study of the occurrence and natural history of knee and hip 
OA in Johnston County, North Carolina, an area currently transitioning from rural to 
suburban. The study was designed to be representative of the civilian, noninstitutionalized, 
English-speaking black and white population age ≥45 years who were residents of 1 of 6 
selected townships of Johnston County for at least 1 year. Participants had to be physically 
and mentally capable of completing the study protocol. The study protocol was approved by 
the Institutional Review Boards of the Centers for Disease Control and Prevention and the 
University of North Carolina School of Medicine. The study has been described elsewhere 
in detail (10,11).
The study protocol at both baseline (1990–1997) and first followup (1999–2003) included 
an initial home interview, clinical examination (with radiographs and height and weight 
measurements), and a second home interview ~2 weeks following clinical examination. 
Radiograph results included anteroposterior views of the knees with weight-bearing and foot 
map positioning, which were read by a single bone and joint radiologist (JBR) for 
radiographic knee OA using Kellgren/Lawrence (K/L) scale grades. A K/L scale grade of ≥2 
indicates the presence of at least mild radiographic OA (12). K/L scale grades, the most 
commonly used measures in epidemiologic studies of radiographic knee OA (13), have been 
MURPHY et al. Page 2













demonstrated to have high intrarater and interrater reliability (13), are highly correlated with 
knee pain (13,14), and are the recommended standard for population-based studies of 
radiographic knee OA (14). The intrarater and interrater reliabilities of the Johnston County 
OA Project radiologist were previously determined to be high, with weighted kappas of 0.89 
and 0.86, respectively (10).
Sociodemographic and clinical characteristics of participants, including sex, race, education, 
income, history of knee injury, weight at age 18 years, and presence of knee symptoms, 
were assessed in an interviewer-administered questionnaire. Symptoms were determined 
through a question about each knee: “On MOST days do you have pain, aching, or stiffness 
in your LEFT (or RIGHT) knee?”
Symptomatic knee OA was defined as a K/L scale radiographic grade of ≥2 (at least mild 
radiographic OA) and symptoms in the same knee. We focused on symptomatic knee OA 
because it is relevant for both clinical diagnosis and measuring the public health burden of 
knee OA. The primary indication for most knee joint replacements is symptomatic OA (15); 
therefore, knees that had undergone total joint replacement were coded as affected. Knees 
with radiographic evidence of inflammatory arthritis (i.e., rheumatoid arthritis) were 
excluded in the analysis.
Statistical analysis
Participants were characterized at baseline by age (categorized in 5-year groupings), sex, 
race (black or white), education (less than high school, high school completed, or greater 
than high school), household income (<$10,000, $10,000 to <$20,000, $20,000 to <$35,000, 
or ≥$35,000), history of knee injury (no/yes), and presence of symptomatic knee OA. Body 
mass index (BMI) of participants was examined at 2 time points: age 18 years (<25 kg/m2 
[underweight/normal weight] or ≥25 kg/m2 [overweight/obese, aggregated due to limited 
sample size]) and baseline (<25 kg/m2 [underweight/normal weight], 25 to <30 kg/m2 
[overweight], or ≥30 kg/m2 [obese]).
Lifetime risk estimates were derived from logistic regression models with generalized 
estimating equations (GEEs). Age was the predictor variable, symptomatic knee OA was the 
outcome variable, and lifetime risk was the predicted probability of developing OA in at 
least 1 knee by age 85 years. Stratified lifetime risk estimates were also generated for the 
following demographic variables: sex, race, education, BMI, and history of knee injury. 
BMI was analyzed in 2 forms: as a summary of BMI over the life course (categorized as <25 
kg/m2 or ≥25 kg/m2 at age 18 years, baseline, and followup), and BMI at baseline and 
followup (each categorized as <25 kg/m2, ≥25 to <30 kg/m2, or ≥30 kg/m2). Lifetime risks 
were derived from models with only age and the stratified variable of interest as independent 
variables. The 95% confidence intervals (95% CIs) for all estimates were derived using the 
SEs of the model-predicted probabilities.
OA symptoms may be intermittent (16). To determine the degree to which changes in 
symptom status would lead to underestimation of lifetime risk, we examined the distribution 
of symptoms at baseline and followup among those with a radiographic K/L scale grade of 
≥2 for OA at baseline and/or followup.
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Sampling weights were applied during modeling to adjust the sample data to the 1990 
Johnston County population distribution. The methods for calculating the sampling weights 
have been described elsewhere (11). During the statistical modeling, adjustment was made 
for the 3 sources of correlated error resulting from the survey design: repeated measures 
across study participants, multiple participants per household, and the 2-stage clustered 
sample design. Lifetime risks were estimated using SUDAAN software (17). Additional 
details on the statistical methods are shown in Appendix A (available at the Arthritis Care & 
Research Web site at http://www.interscience.wiley.com/jpages/0004-3591:1/suppmat/
index.html).
Longitudinal studies (i.e., baseline and followup data) pose special design and analytic 
challenges. First, participants with baseline and followup data have repeated measurements 
that may be correlated; therefore, GEE methods were used because this modeling procedure 
correctly accounts for repeated measures and their correlation with each other (18,19). 
Followup data were obtained for a subset (52%) of the baseline cohort, and use of the GEE 
approach enabled estimation of risk from individuals with single (either baseline or 
followup) or multiple (both baseline and followup) outcome measures. Second, attrition is a 
universal issue in longitudinal cohort studies. The Johnston County OA Project used various 
strategies to minimize cohort attrition (e.g., annual newsletters, notices in local media and in 
medical and community settings, contacts, medical providers, and community inquiries) and 
to identify people who had died between baseline and followup (e.g., review of local 
obituaries, word of mouth, knowledge of local project staff, and local, state, and national 
[National Death Index] death records). Nevertheless, followup data were unavailable for 
some of the inception cohort, and therefore we conducted sensitivity analyses (see Appendix 
B, available at the Arthritis Care & Research Web site at http://
www.interscience.wiley.com/jpages/0004-3591:1/suppmat/index.html) to examine the 
potential bias resulting from cohort attrition.
Lifetime risk is the cumulative probability, or cumulative incidence, of a condition in a 
cohort. In this study, cumulative incidence equals lifetime prevalence because symptomatic 
knee OA is a persistent, low-mortality condition. Lifetime risk differs from point prevalence 
in that point prevalence captures cases in a cohort at a single point in time, whereas lifetime 
risk is a cumulative measure (i.e., collected at multiple time points) of information among 
cohort members and includes persons who may subsequently die or leave the cohort for 
other reasons (e.g., move outside the catchment area). All cohort members (n = 3,068), 
regardless of OA status at baseline, were included in this analysis. The inclusion of 
prevalent and incident cases is also necessary in estimating lifetime risk of symptomatic OA, 
because symptoms may be intermittent or abate (e.g., response to treatment of symptoms); 
this approach ensures a greater likelihood that persons who have ever had symptomatic OA 
are included in the estimate.
RESULTS
The mean age of the baseline sample was 61 years (range 45–93), and the mean time 
between baseline and followup was 6.0 years (range 3.5–13.2). The baseline cohort 
comprised a higher weighted proportion of women than men (57.4% versus 42.6%), and 
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more whites than blacks (81.6% versus 18.4%) (Table 1). Two-thirds of the sample were 
married, 17.6% had an annual household income ≥$35,000, and the majority of patients had 
at least a high school education (60.1%). Whereas almost two-thirds (63.5%) of the sample 
were overweight or obese as measured at baseline, only one-tenth (10.4%) reported to be so 
at age 18 years. A history of knee injury was reported by 15.7% of respondents. The 
prevalence of symptomatic knee OA was 15.2% in the baseline cohort and 5.4% of the 
respondents with symptomatic knee OA had radiographic evidence of knee replacements. Of 
the 2,228 participants eligible for inclusion in the first followup, 1,590 (71.3%) participated 
in both a clinical examination and a household interview (Figure 1). Of the participants with 
a radiographic K/L scale grade of ≥2 for knee OA at baseline and/or followup, 80% were 
symptomatic at baseline and/or followup, and 63% of the sample with radiographic knee OA 
were symptomatic at both time points. The un-weighted frequency of symptomatic knee OA 
status at baseline and followup by 5-year age groups is shown in Appendix C (available at 
the Arthritis Care & Research Web site at http://www.interscience.wiley.com/jpages/
0004-3591:1/suppmat/index.html).
The lifetime risk of symptomatic knee OA (i.e., developing the condition by age 85 years) 
was 44.7% (95% CI 40.0–49.3%) overall (Table 2). Although there were no significant 
differences by sex, race, and education, obese participants had a significantly higher lifetime 
risk (60.5% compared with 30.2% and 46.9% among those who were normal weight and 
overweight, respectively), as did those with a history of knee injury (56.8% compared with 
42.3% without a history of knee injury). In the sensitivity analyses, which estimated the 
influence of missing data for 6 followup groups, we observed a lifetime risk of 41.3% when 
all groups were recoded, and 45.3% for 5 groups (excluding those who were deceased at 
followup) (Appendix B).
The analysis of BMI across the life course indicated that those who had a normal weight at 
the 3 time points examined (age 18 years, baseline, and followup) had the lowest lifetime 
risk (29.2%; 95% CI 15.8–42.7%), whereas those who reported a normal weight at age 18 
years but were overweight or obese at the 2 later time points had the highest risk (59.9%; 
95% CI 51.8–68.1%). These estimates were significantly different (P < 0.001) (Figure 2).
DISCUSSION
In this study, lifetime risk was the probability of a person developing symptomatic OA in at 
least 1 knee by age 85 years. We found the lifetime risk of symptomatic knee OA to be 
nearly 1 in 2 overall, more than 1 in 2 among those with history of a knee injury, and nearly 
2 in 3 for obese persons. Comparison of BMI patterns over the life course suggested that 
higher BMI at later ages accounted for the greatest variability in lifetime risk estimates 
(Figure 2); for example, the lifetime risk among those who had a normal BMI at age 18 
years but who were overweight/obese at baseline, and followup was twice that of those who 
had a normal BMI at each of the 3 time periods. The latter results are comparable with those 
of Dawson et al, who examined the association between life-course BMI and the prevalence 
of symptomatic knee OA, and reported that BMI >25 kg/m2 at older ages (i.e., 36–40 years, 
51–56 years) was most strongly associated with symptomatic knee OA (20).
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Our estimates of lifetime risk are potentially underestimated. First, the youngest Johnston 
County OA Project cohort members were age 45 years at baseline, the lower age limit for 
the OA Project, because OA is very uncommon among people age <45 years (3,21). 
Nevertheless, the omission of younger age groups may contribute to a slight underestimation 
of lifetime risk. Second, previous studies indicate that OA symptoms may be intermittent 
(16). Of those respondents with a radiographic K/L scale grade of ≥2 for OA at baseline 
and/or followup, 20% did not report symptoms at baseline or followup. Although analysis of 
symptomatic disease status at 2 points increased the likelihood of detecting symptomatic and 
radiographic knee OA, any of these respondents who experienced knee symptoms other than 
at baseline and followup were coded as unaffected in this analysis. Third, this analysis is 
based on multiple birth cohorts, which assume no period or cohort effects in OA onset, and 
the fact that the age-specific disease rates experienced by older members of the sample will 
be the same for the younger members across time. However, an increase in the prevalence of 
a major risk factor for OA—overweight/obesity—among the younger cohort members 
would result in an even greater estimate of lifetime risk. Finally, radiographic patellofemoral 
joint OA was not measured in this study, although it also contributes to symptomatic knee 
OA.
This study has several limitations. To our knowledge, the Johnston County OA Project is 
one of the largest longitudinal population-based studies of knee and hip OA in the US. 
Nevertheless, the limited sample size decreased the precision of the point estimates, and 
likely prevented detection of statistically significant differences between subgroups (e.g., 
comparison of BMI across the life course). Also, although baseline and followup weights 
were measured by clinic staff to ensure accuracy of information, weight at age 18 years was 
self-reported and was likely underestimated by many respondents. Our analysis examined 
multiple factors for which there is at least moderate evidence of an etiologic association with 
symptomatic knee OA (20,22,23). We did not analyze lifetime risk in association with work 
history, because such an analysis is complex and outside the scope of this study.
This study also has several strengths. First, the use of GEE repeated-measures modeling 
reduced selection bias and increased statistical power, because data for all cohort members 
were analyzed regardless of followup status. Second, the mean followup time of 6.0 years is 
sufficient to detect new cases, because several recent longitudinal studies of OA progression 
have had similar or even less followup time (range of mean followup time 18 months to 6.6 
years) (24–28). Third, the Johnston County OA Project is not only one of the largest 
longitudinal studies of patients with OA, but it is also one of only a few studies to include 
both blacks and whites; the data provide a limited opportunity to estimate lifetime risk in a 
racially-mixed sample. Fourth, various strategies were used to maximize survey 
participation, which resulted in a response rate that was the same as, or higher than, other 
community-based, racially-mixed longitudinal studies of middle-aged and older adults (29–
31). The sensitivity analyses, designed to assess the effect of missing data encountered in all 
such longitudinal studies, found a mortality-adjusted lifetime risk of 45.3%, a result so 
similar to the main analysis (45.5%) that study results were unlikely to be biased by the 
missing followup data.
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Longitudinal studies of knee OA have been confined to small geographic areas because knee 
OA is difficult to diagnose without costly knee radiographs. Self-reported knee pain is not 
an accurate method of identifying knee OA, given the competing causes of knee pain (e.g., 
soft-tissue and widespread pain disorders and other arthropathies). Sampling weights were 
applied to derive estimates generalizable to the 1990 Johnston County population, but 
generalizing the Johnston County findings to the US population should be approached with 
caution. Although the distribution of age, sex, and BMI of the Johnston County and US 
populations were similar in 1990 (one-third of residents in both jurisdictions were age ≥45 
years; 12.6% and 12.1% were age ≥65 years, respectively), approximately 51% were 
women, and two-thirds were overweight (66% in the study sample and 65% among US 
black and white adults age ≥45 years [Third National Health and Nutrition Examination 
Survey, 1988–1994]) (32–34), the Johnston County population was more likely than the US 
population to be black (18% versus 12%), live in a rural area (76% versus 25%), be less 
educated (35% versus 25% had not completed high school), and have a lower income 
(median income $25,169 versus $30,056).
To our knowledge, the Johnston County OA Project is the only longitudinal, population-
based study of patients with knee and hip OA in the US that includes blacks and whites of 
both sexes who are middle-aged and older from the same geographic area, and the lifetime 
risk estimates we have reported were derived from a sociodemographically diverse sample. 
Estimating prevalence and incidence density among people age ≥85 years is typically 
challenging in epidemiologic studies because of decreased survival to this age. However, the 
lifetime risk statistic is a cumulative measure and uses pooled information from across age 
groups, enabling estimation of disease risk at age 85 years with increased precision. 
Furthermore, the lifetime risk statistic is an epidemiologic measure that is familiar to the 
general public, because it has been used to convey the person-level risk of other chronic 
conditions, including breast cancer; lifetime risk is thought to be a more accessible statistic 
for describing risk to lay audiences (35). Other lifetime risk studies have reported higher 
probabilities with increasing observation time (6,7,36), suggesting that the lifetime risks 
demonstrated here will increase with subsequent followup.
Although Johnston County is a lower-income rural area in the Southern US, the high 
lifetime risks observed in this population-based sample suggest that the lifetime risk of 
symptomatic knee OA is likely high in the US and other populations, especially given the 
aging of the population and the increasing prevalence of obesity (37,38). Results from this 
study indicate that nearly 1 in 2 people are at risk of developing symptomatic OA in at least 
1 knee, and that 2 in 3 obese people are at risk. Weight loss can lead to a decreased risk of 
symptomatic knee OA (39), and the association between the modifiable risk factor, BMI, 
and lifetime risk of OA in this study further underscores the need for public health weight 
loss and management interventions that would contribute to a decreased lifetime risk of OA. 
Those in the rheumatologic field have lamented the lack of attention given to arthritis in 
public health planning and policy making, given the high prevalence, tremendous costs, and 
disability associated with knee OA (40). We have presented the lifetime risk estimate to 
further illustrate the significant public health burden of this condition.
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Status of Johnston County Osteoarthritis Project baseline participants at first followup. * = 
baseline response rate 3,068 (60%) out of 5,138, clinic completion rate 3,068 (83%) out of 
3,690; † = first followup response rate 1,590 (71%) out of 2,228, clinic completion rate 
1,590 (91%) out of 1,739.
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Lifetime risk of symptomatic knee osteoarthritis by body mass index (BMI) at age 18 years, 
baseline, and followup (n = 1,523). Baseline and followup height and weight measured by 
study staff during clinic visit. Comparison of NNN with NOO, P < 0.001. N = normal (BMI 
<25 kg/m2); O = overweight or obese (BMI ≥25 kg/m2).
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Table 1




























 Less than high school 39.9
 High school completed 32.6
 Greater than high school 27.5
BMI at age 18 years, kg/m2‡
 <25 (underweight and normal weight) 86.9
 ≥25 (overweight and obese) 10.4
 Missing 2.7
BMI, kg/m2
 <25 (underweight and normal weight) 32.9
 25–<30 (overweight) 39.5
 ≥30 (obese) 24.0
 Missing 3.4
History of knee injury


















Pain, aching, or stiffness in at least 1
  knee§
42.5¶
Symptomatic OA in at least 1 knee# 15.6




Weighted to Johnston County population distribution in 1990 US Census. BMI = body mass index; OA = osteoarthritis.
†
Sum of percentages do not add up to 100% because of rounding.
‡
Weight at age 18 years was self-reported.
§
Participants who reported pain, aching, and stiffness in at least 1 knee, regardless of radiographic status of the knee.
¶
Baseline knee symptom status unknown for 62 (2.0%) persons.
#
Includes knees with total joint replacement. Baseline knee radiographic status unknown for 53 (1.4%) persons. Kellgren/Lawrence scale 
radiographic grade ≥2
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Table 2




 Men 39.8 (32.2–47.3)
 Women 46.8 (41.2–52.5)
 Race
  Black 50.1 (41.8–58.4)
  White 43.8 (38.4–49.1)
 Education†
  Less than high school 43.5 (37.5–49.5)
  High school completed 51.9 (42.2–61.6)
  Greater than high school 34.8 (25.8–43.8)
 BMI, kg/m2†
  <25 (underweight and
   normal weight)
30.2 (23.0–37.4)‡
  25–<30 (overweight) 46.9 (39.3–54.5)§
  ≥30 (obese) 60.5 (53.0–68.1)
 History of knee injury†
  No 42.3 (37.2–47.4)
  Yes 56.8 (48.4–65.2)¶
Overall 44.7 (40.0–49.3)
*
Symptomatic knee OA is Kellgren/Lawrence scale radiographic grade ≥2. 95% CI = 95% confidence interval; OA = osteoarthritis; BMI = body 
mass index.
†
Education, BMI, and history of knee injury in these models were time dependent (e.g., education of participants at each time point was analyzed).
‡
Comparison of lifetime risk, normal weight and obese, P < 0.0001.
§
Comparison of lifetime risk, overweight and obese, P = 0.01.
¶
Comparison of lifetime risk, history of knee injury (no and yes), P = 0.002.
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